IFM Therapeutics ‘Lather, Rinse, Repeat’ Strategy On Track With $55M Financing

 
• By Jessica Merrill

The drug discovery company with a big pharma deal-making track record is launching a new subsidiary, IFM Quattro, and a drug discovery incubator, IFM Discovery. Scrip talked to IFM's new CEO Martin Seidel about what is ahead for the company.

close up foam in two hand isolated on white background. - Image
IFM Therapeutics is lathering up its next round of drug discovery • Source: Shutterstock

More from Financing

More from Business